Results suggested that following the PI3K/Akt/mTOR signaling pathway, tangeretin effectively induced reprogramming of epithelial to mesenchymal transition and the expression level of mesenchymal proteins in prostate cancer cells was reduced [108]. The gene discussed is MTOR; the disease is prostate carcinoma.